Enteric Disease Testing - Global Market Outlook (2017-2023)
According to Stratistics MRC, the Global Enteric Disease Testing Market is accounted from $4.02 billion in 2016 to reach $5.33 billion by 2023 with a CAGR of 4.1%. Factors such as growing occurrence of enteric bacterial infection, increasing technological advancements in the field of molecular diagnostics and rising medical testing for enteric disease are fueling the market growth. However, rising awareness in developing nations and strict regulations are hampering the growth of the market. Expanding in molecular diagnostics based enteric disease testing is one of the new opportunities for the growth of the market.
Enteric diseases are gastrointestinal infections effected by microbes such as bacteria, viruses, and parasites as they enter the body throughout the mouth or intestinal systems. Enteric infections, with or without overt diarrhea, have profound effects on intestinal absorption, nutrition, and childhood development as well as on global mortality.
By disease type, parasitic diseases continue to cause significant morbidity and mortality throughout the world. Even though the frequency and severity of parasitic diseases are mainly excessive in the emerging world, changes in worldwide travel, immigration, commerce, and day care for young children and rising quantity of patients with immune cooperation have lead to improved prevalence of parasitic diseases in the world. Parasitic disease might imitate other gastrointestinal diseases, such as inflammatory bowel disease, hepatitis, sclerosing cholangitis, peptic ulcer disease, and celiac disease. Parasitic disease can also generate explicit manifestations of quiescent chronic intestinal disorders.
North America commanded the largest market share attributes to huge demand for molecular diagnostic tests and the high level of enteric disorder awareness among the population.
Some of the key players in Enteric Disease Testing market include Becton, Dickinson & Company, Cepheid, Bio Rad Laboratories, DiaSorin, Alere Inc., Quest Diagnostics, Thermo Fisher Scientific, Trinity Biotech, Mobidiag, Siemens, Biomerica Inc., R-Biopharm, Coris BioConcept, bioMerieux and Meridian BioSceinces.
Disease Types Covered:
Enteric diseases are gastrointestinal infections effected by microbes such as bacteria, viruses, and parasites as they enter the body throughout the mouth or intestinal systems. Enteric infections, with or without overt diarrhea, have profound effects on intestinal absorption, nutrition, and childhood development as well as on global mortality.
By disease type, parasitic diseases continue to cause significant morbidity and mortality throughout the world. Even though the frequency and severity of parasitic diseases are mainly excessive in the emerging world, changes in worldwide travel, immigration, commerce, and day care for young children and rising quantity of patients with immune cooperation have lead to improved prevalence of parasitic diseases in the world. Parasitic disease might imitate other gastrointestinal diseases, such as inflammatory bowel disease, hepatitis, sclerosing cholangitis, peptic ulcer disease, and celiac disease. Parasitic disease can also generate explicit manifestations of quiescent chronic intestinal disorders.
North America commanded the largest market share attributes to huge demand for molecular diagnostic tests and the high level of enteric disorder awareness among the population.
Some of the key players in Enteric Disease Testing market include Becton, Dickinson & Company, Cepheid, Bio Rad Laboratories, DiaSorin, Alere Inc., Quest Diagnostics, Thermo Fisher Scientific, Trinity Biotech, Mobidiag, Siemens, Biomerica Inc., R-Biopharm, Coris BioConcept, bioMerieux and Meridian BioSceinces.
Disease Types Covered:
- Viral Enteric Disease
- Bacterial Enteric Disease
- Parasitic Enteric Disease
- Other Disease Types
- Conventional Testing
- Immunoassay Testing
- Molecular Diagnostic Testing
- Monoclonal Antibodies
- Information Technology
- Liposomes
- Chromatography
- Gel Microdroplets
- Diagnostic Imaging
- Differential Light Scattering
- Artificial Intelligence
- Flow Cytometry
- Other Technologies
- Diagnostic Laboratories
- Hospitals
- Physician Offices
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- U.K
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
1 EXECUTIVE SUMMARY
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Futuristic Market Scenario
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE
5.1 Introduction
5.2 Viral Enteric Disease
5.2.1 Norovirus Infection
5.2.2 Rotavirus Infection
5.3 Bacterial Enteric Disease
5.3.1 Campylobacteriosis
5.3.2 E.Coli
5.3.3 Salmonellosis
5.3.4 Clostridium Difficile Infection (C. Difficile)
5.3.5 Cholera
5.3.6 Shigellosis
5.3.7 Helicobacter Pylori Enteric Diseases (H.Pylori)
5.4 Parasitic Enteric Disease
5.4.1 Cryptosporidiosis
5.4.2 Amebiasis
5.4.3 Giardiasis
5.5 Other Disease Types
6 GLOBAL ENTERIC DISEASE TESTING MARKET, BY TECHNOLOGY
6.1 Introduction
6.2 Conventional Testing
6.3 Immunoassay Testing
6.4 Molecular Diagnostic Testing
6.5 Monoclonal Antibodies
6.6 Information Technology
6.7 Liposomes
6.8 Chromatography
6.9 Gel Microdroplets
6.10 Diagnostic Imaging
6.11 Differential Light Scattering
6.12 Artificial Intelligence
6.13 Flow Cytometry
6.14 Other Technologies
7 GLOBAL ENTERIC DISEASE TESTING MARKET, BY END USER
7.1 Introduction
7.2 Diagnostic Laboratories
7.3 Hospitals
7.4 Physician Offices
8 GLOBAL ENTERIC DISEASE TESTING MARKET, BY GEOGRAPHY
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 U.K.
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 KEY DEVELOPMENTS
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 COMPANY PROFILING
10.1 Becton, Dickinson & Company
10.2 Cepheid
10.3 Bio Rad Laboratories
10.4 DiaSorin
10.5 Alere Inc.
10.6 Quest Diagnostics
10.7 Thermo Fisher Scientific
10.8 Biomerica
10.9 Trinity Biotech
10.10 Mobidiag
10.11 Siemens
10.12 Biomerica Inc.
10.13 R-Biopharm
10.14 Coris BioConcept
10.15 bioMerieux
10.16 Meridian BioSceinces
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Futuristic Market Scenario
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE
5.1 Introduction
5.2 Viral Enteric Disease
5.2.1 Norovirus Infection
5.2.2 Rotavirus Infection
5.3 Bacterial Enteric Disease
5.3.1 Campylobacteriosis
5.3.2 E.Coli
5.3.3 Salmonellosis
5.3.4 Clostridium Difficile Infection (C. Difficile)
5.3.5 Cholera
5.3.6 Shigellosis
5.3.7 Helicobacter Pylori Enteric Diseases (H.Pylori)
5.4 Parasitic Enteric Disease
5.4.1 Cryptosporidiosis
5.4.2 Amebiasis
5.4.3 Giardiasis
5.5 Other Disease Types
6 GLOBAL ENTERIC DISEASE TESTING MARKET, BY TECHNOLOGY
6.1 Introduction
6.2 Conventional Testing
6.3 Immunoassay Testing
6.4 Molecular Diagnostic Testing
6.5 Monoclonal Antibodies
6.6 Information Technology
6.7 Liposomes
6.8 Chromatography
6.9 Gel Microdroplets
6.10 Diagnostic Imaging
6.11 Differential Light Scattering
6.12 Artificial Intelligence
6.13 Flow Cytometry
6.14 Other Technologies
7 GLOBAL ENTERIC DISEASE TESTING MARKET, BY END USER
7.1 Introduction
7.2 Diagnostic Laboratories
7.3 Hospitals
7.4 Physician Offices
8 GLOBAL ENTERIC DISEASE TESTING MARKET, BY GEOGRAPHY
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 U.K.
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 KEY DEVELOPMENTS
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 COMPANY PROFILING
10.1 Becton, Dickinson & Company
10.2 Cepheid
10.3 Bio Rad Laboratories
10.4 DiaSorin
10.5 Alere Inc.
10.6 Quest Diagnostics
10.7 Thermo Fisher Scientific
10.8 Biomerica
10.9 Trinity Biotech
10.10 Mobidiag
10.11 Siemens
10.12 Biomerica Inc.
10.13 R-Biopharm
10.14 Coris BioConcept
10.15 bioMerieux
10.16 Meridian BioSceinces
LIST OF TABLES
Table 1 Global Enteric Disease Testing Market Outlook, By Region (2015-2023) ($MN)
Table 2 Global Enteric Disease Testing Market Outlook, By Disease Type (2015-2023) ($MN)
Table 3 Global Enteric Disease Testing Market Outlook, By Viral Enteric Disease (2015-2023) ($MN)
Table 4 Global Enteric Disease Testing Market Outlook, By Norovirus Infection (2015-2023) ($MN)
Table 5 Global Enteric Disease Testing Market Outlook, By Rotavirus Infection (2015-2023) ($MN)
Table 6 Global Enteric Disease Testing Market Outlook, By Bacterial Enteric Disease (2015-2023) ($MN)
Table 7 Global Enteric Disease Testing Market Outlook, By Campylobacteriosis (2015-2023) ($MN)
Table 8 Global Enteric Disease Testing Market Outlook, By E.Coli (2015-2023) ($MN)
Table 9 Global Enteric Disease Testing Market Outlook, By Salmonellosis (2015-2023) ($MN)
Table 10 Global Enteric Disease Testing Market Outlook, By Clostridium Difficile Infection (C. Difficile) (2015-2023) ($MN)
Table 11 Global Enteric Disease Testing Market Outlook, By Cholera (2015-2023) ($MN)
Table 12 Global Enteric Disease Testing Market Outlook, By Shigellosis (2015-2023) ($MN)
Table 13 Global Enteric Disease Testing Market Outlook, By Helicobacter Pylori Enteric Diseases (H.Pylori) (2015-2023) ($MN)
Table 14 Global Enteric Disease Testing Market Outlook, By Parasitic Enteric Disease (2015-2023) ($MN)
Table 15 Global Enteric Disease Testing Market Outlook, By Cryptosporidiosis (2015-2023) ($MN)
Table 16 Global Enteric Disease Testing Market Outlook, By Amebiasis (2015-2023) ($MN)
Table 17 Global Enteric Disease Testing Market Outlook, By Giardiasis (2015-2023) ($MN)
Table 18 Global Enteric Disease Testing Market Outlook, By Other Disease Types (2015-2023) ($MN)
Table 19 Global Enteric Disease Testing Market Outlook, By Technology (2015-2023) ($MN)
Table 20 Global Enteric Disease Testing Market Outlook, By Conventional Testing (2015-2023) ($MN)
Table 21 Global Enteric Disease Testing Market Outlook, By Immunoassay Testing (2015-2023) ($MN)
Table 22 Global Enteric Disease Testing Market Outlook, By Molecular Diagnostic Testing (2015-2023) ($MN)
Table 23 Global Enteric Disease Testing Market Outlook, By Monoclonal Antibodies (2015-2023) ($MN)
Table 24 Global Enteric Disease Testing Market Outlook, By Information Technology (2015-2023) ($MN)
Table 25 Global Enteric Disease Testing Market Outlook, By Liposomes (2015-2023) ($MN)
Table 26 Global Enteric Disease Testing Market Outlook, By Chromatography (2015-2023) ($MN)
Table 27 Global Enteric Disease Testing Market Outlook, By Gel Microdroplets (2015-2023) ($MN)
Table 28 Global Enteric Disease Testing Market Outlook, By Diagnostic Imaging (2015-2023) ($MN)
Table 29 Global Enteric Disease Testing Market Outlook, By Differential Light Scattering (2015-2023) ($MN)
Table 30 Global Enteric Disease Testing Market Outlook, By Artificial Intelligence (2015-2023) ($MN)
Table 31 Global Enteric Disease Testing Market Outlook, By Flow Cytometry (2015-2023) ($MN)
Table 32 Global Enteric Disease Testing Market Outlook, By Other Technologies (2015-2023) ($MN)
Table 33 Global Enteric Disease Testing Market Outlook, By End User (2015-2023) ($MN)
Table 34 Global Enteric Disease Testing Market Outlook, By Diagnostic Laboratories (2015-2023) ($MN)
Table 35 Global Enteric Disease Testing Market Outlook, By Hospitals (2015-2023) ($MN)
Table 36 Global Enteric Disease Testing Market Outlook, By Physician Offices (2015-2023) ($MN)
Note: Tables for North America, Europe, APAC, South America and Middle East & Africa Regions are also represented in the same manner as above
Table 1 Global Enteric Disease Testing Market Outlook, By Region (2015-2023) ($MN)
Table 2 Global Enteric Disease Testing Market Outlook, By Disease Type (2015-2023) ($MN)
Table 3 Global Enteric Disease Testing Market Outlook, By Viral Enteric Disease (2015-2023) ($MN)
Table 4 Global Enteric Disease Testing Market Outlook, By Norovirus Infection (2015-2023) ($MN)
Table 5 Global Enteric Disease Testing Market Outlook, By Rotavirus Infection (2015-2023) ($MN)
Table 6 Global Enteric Disease Testing Market Outlook, By Bacterial Enteric Disease (2015-2023) ($MN)
Table 7 Global Enteric Disease Testing Market Outlook, By Campylobacteriosis (2015-2023) ($MN)
Table 8 Global Enteric Disease Testing Market Outlook, By E.Coli (2015-2023) ($MN)
Table 9 Global Enteric Disease Testing Market Outlook, By Salmonellosis (2015-2023) ($MN)
Table 10 Global Enteric Disease Testing Market Outlook, By Clostridium Difficile Infection (C. Difficile) (2015-2023) ($MN)
Table 11 Global Enteric Disease Testing Market Outlook, By Cholera (2015-2023) ($MN)
Table 12 Global Enteric Disease Testing Market Outlook, By Shigellosis (2015-2023) ($MN)
Table 13 Global Enteric Disease Testing Market Outlook, By Helicobacter Pylori Enteric Diseases (H.Pylori) (2015-2023) ($MN)
Table 14 Global Enteric Disease Testing Market Outlook, By Parasitic Enteric Disease (2015-2023) ($MN)
Table 15 Global Enteric Disease Testing Market Outlook, By Cryptosporidiosis (2015-2023) ($MN)
Table 16 Global Enteric Disease Testing Market Outlook, By Amebiasis (2015-2023) ($MN)
Table 17 Global Enteric Disease Testing Market Outlook, By Giardiasis (2015-2023) ($MN)
Table 18 Global Enteric Disease Testing Market Outlook, By Other Disease Types (2015-2023) ($MN)
Table 19 Global Enteric Disease Testing Market Outlook, By Technology (2015-2023) ($MN)
Table 20 Global Enteric Disease Testing Market Outlook, By Conventional Testing (2015-2023) ($MN)
Table 21 Global Enteric Disease Testing Market Outlook, By Immunoassay Testing (2015-2023) ($MN)
Table 22 Global Enteric Disease Testing Market Outlook, By Molecular Diagnostic Testing (2015-2023) ($MN)
Table 23 Global Enteric Disease Testing Market Outlook, By Monoclonal Antibodies (2015-2023) ($MN)
Table 24 Global Enteric Disease Testing Market Outlook, By Information Technology (2015-2023) ($MN)
Table 25 Global Enteric Disease Testing Market Outlook, By Liposomes (2015-2023) ($MN)
Table 26 Global Enteric Disease Testing Market Outlook, By Chromatography (2015-2023) ($MN)
Table 27 Global Enteric Disease Testing Market Outlook, By Gel Microdroplets (2015-2023) ($MN)
Table 28 Global Enteric Disease Testing Market Outlook, By Diagnostic Imaging (2015-2023) ($MN)
Table 29 Global Enteric Disease Testing Market Outlook, By Differential Light Scattering (2015-2023) ($MN)
Table 30 Global Enteric Disease Testing Market Outlook, By Artificial Intelligence (2015-2023) ($MN)
Table 31 Global Enteric Disease Testing Market Outlook, By Flow Cytometry (2015-2023) ($MN)
Table 32 Global Enteric Disease Testing Market Outlook, By Other Technologies (2015-2023) ($MN)
Table 33 Global Enteric Disease Testing Market Outlook, By End User (2015-2023) ($MN)
Table 34 Global Enteric Disease Testing Market Outlook, By Diagnostic Laboratories (2015-2023) ($MN)
Table 35 Global Enteric Disease Testing Market Outlook, By Hospitals (2015-2023) ($MN)
Table 36 Global Enteric Disease Testing Market Outlook, By Physician Offices (2015-2023) ($MN)
Note: Tables for North America, Europe, APAC, South America and Middle East & Africa Regions are also represented in the same manner as above
